Amarin Corp Plcuk (AMRN) Gross Profit (2013 - 2026)
Amarin Corp Plc\Uk (AMRN) posted quarterly Gross Profit of $15.0 million for Q2 2026, down 70.24% year-over-year from $50.4 million in Q2 2025, and down 15.65% quarter-over-quarter from $17.8 million in Q1 2026.
Amarin Corp Plcuk (AMRN) Gross Profit (2013 - 2026) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Gross Profit for 14 consecutive years, with $15.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Gross Profit fell 70.24% year-over-year to $15.0 million; the TTM figure through Jun 2026 stood at $78.1 million (down 4.95% YoY), while the FY2025 annual figure was $120.9 million, up 48.52% from the prior year.
- Gross Profit eased to $15.0 million in Q2 2026 per AMRN's latest filing, from $17.8 million in the prior quarter.
- Across five years, Gross Profit topped out at $72.4 million in Q1 2022 and bottomed at -$9.6 million in Q4 2024.
- Historically, Gross Profit has averaged $35.7 million across 5 years, with a median of $37.3 million in 2023.
- Annual changes were most pronounced in 2024 — Gross Profit tumbled 121.2% — and 2025, when it surged 342.18%.
- Amarin Corp Plc\Uk's Gross Profit stood at $63.6 million in 2022, then slipped by 29.05% to $45.1 million in 2023, then plunged by 121.2% to -$9.6 million in 2024, then soared by 342.18% to $23.2 million in 2025, then tumbled by 35.31% to $15.0 million in 2026.
- Business Quant data shows AMRN's Gross Profit at $15.0 million in Q2 2026, $17.8 million in Q1 2026, and $23.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.99 Mn |
| Jun 30, 2026 | 14.99 Mn |
| Mar 31, 2026 | 17.77 Mn |
| Mar 31, 2026 | 17.77 Mn |
| Dec 31, 2025 | 23.17 Mn |
| Dec 31, 2025 | 23.17 Mn |
| Sep 30, 2025 | 22.21 Mn |
| Sep 30, 2025 | 22.21 Mn |
| Jun 30, 2025 | 50.36 Mn |
| Jun 30, 2025 | 50.36 Mn |
| Mar 31, 2025 | 25.13 Mn |
| Mar 31, 2025 | 25.13 Mn |
| Dec 31, 2024 | -9.57 Mn |
| Dec 31, 2024 | -9.57 Mn |
| Sep 30, 2024 | 16.28 Mn |
| Sep 30, 2024 | 16.28 Mn |
| Jun 30, 2024 | 42.77 Mn |
| Jun 30, 2024 | 42.77 Mn |
| Mar 31, 2024 | 31.90 Mn |
| Mar 31, 2024 | 31.90 Mn |